Transforming Medicines Manufacturing
Innovate UK’s Medicines Manufacturing programmes aim to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.
About the programme
The Transforming Medicines Manufacturing (TMM) programme leads on from the ISCF Medicines Manufacturing Challenge Community, which was established in 2017 and ran until 2022, and has been designed to support and grow the UK’s capabilities in manufacturing medicines by developing first-of-a-kind technologies to accelerate patient access to new drugs and treatments.
TMM consists of a range of funding competitions as well as a Community of Practice which will include a range of face-to-face events, interactive workshops and webinars amongst other activities.
- De-risk the use of technologies in innovative manufacturing.
- Drive disruptive technology innovation of long-term strategic importance.
- Build resilience and growth in the medicines manufacturing sector ensuring health security and patient benefit.
- Support economic recovery and levelling up through supporting job creation, skills development and encouraging inward investment.
- Supporting ambitious ED&I goals across the sector to establish a culture of change.
- Address the Net Zero agenda and sustainability goals through funding novel manufacturing technologies to improve yields reduce waste and cut emissions.
Transforming Medicines Manufacturing introduction
The key to the UK’s future as a global medicines manufacturing hub is its people. The Medicines Manufacturing Challenge has laid the groundwork for building this highly skilled workforce, but we need to continue to nurture the pipeline for the next generation of scientists, engineers and technicians to maintain a thriving industry.
Nucleic Acid Medicines Manufacturing
Improving the resource efficiency, productivity, and scalability for the manufacture of nucleic acid medicines.
Digitalisation and automation
Driving digitalisation and automation technologies in the development and manufacture of medicines.
Intracellular drug delivery
Development and manufacturing of innovative formulations for DNA and RNA-based medicines.
Flexible, Agile, Sustainable, Scalable Technologies
Investing in advanced manufacturing technologies for better, more responsive manufacturing approaches.
Simplified Delivery of Complex Medicines
Accelerating innovation in complex medicines formulation, manufacturing, and delivery.
The Community of Practice
A collaborative forum, bringing together key stakeholders to drive forward cutting-edge innovation in medicines manufacturing in the UK.
Innovate UK Investor Partnerships: SME round 6
Opens: 09/01/2024 Closes: 27/02/2024
UK registered SMEs can apply for grant funding alongside private investment from selected investor partners.
Global Incubator Programme: Canada - AI in Health
Opens: 22/01/2024 Closes: 15/03/2024
Innovate UK EDGE seeks up to 8 companies developing health tech using AI-powered solutions to join a programme working with Canada.
Scottish EDGE Round 23
Opens: 07/02/2024 Closes: 06/03/2024
Scottish EDGE, Scotland’s biggest business funding competition, offers grants & loans from £10k to £100k to grow your startup, social enterprise or charity.
Help us shape the future of innovation!
Innovate UK is looking to expand their assessor pool to review applications in the Health and Life Sciences area. Join us and be part of a vibrant community of experts dedicated to driving innovation forward.
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.
Join the community
Join the medicines manufacturing community of practice to stay up to date with the latest news, grant funding, policy changes and regulatory announcements. Interact and collaborate with other organisations and help shape the future of medicines manufacturing in the UK.